01.12.2015
- Israeli generics giant Teva and Japanese drugmaker Takeda have agreed to form a partnership to address the growing importance of generics in Japan. The 51:49 joint venture, which...
16.11.2015
- Mylan’s seven month-long, $26 billion long-shot hostile bid for Perrigo has ended in defeat for the Netherlands-based drugmaker. By the target deadline of Friday, Nov. 13, only 40%...
13.10.2015
- Israeli generics giant Teva Pharmaceutical Industries has launched a generic equivalent to Glaxo SmithKline’s Avodart (dutasteride) 0.5 mg capsules on the US market. The active...
25.09.2015
- Following the green light from health regulator European Medicines Agency, the European Commission is expected to decide on a final approval for GlaxoSmithKline’s (GSK) injectable...
10.09.2015
- Mylan has announced a fresh $27.14 billion offer for generic drug and ingredients maker Perrigo. The Ireland-based drugmaker previously rejected several offers from its Netherlands...
02.09.2015
- Fresh from completing its acquisition of GlaxoSmithKline’s OTC business, Ireland-domiciled pharmaceutical producer Perrigo has acquired ScarAway, a leading OTC scar management...
27.08.2015
- A court in Indiana, USA, has ruled in Eli Lilly’s favor in a long-running patent battle with Teva Pharmaceutical Industries relating to infringement of the vitamin regimen for its...
30.07.2015
- In the latest spectacular takeover to occupy the attention of the international pharmaceuticals sector, Israeli generics giant Teva has agreed to pay $40.5 billion cash and stock...
